Hidetaka Masuda
About
In The Last Decade
Hidetaka Masuda
32 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 643
- Oncology 526
- Pathology and Forensic Medicine 253
- Cancer Research 151
- Organic Chemistry 124
Countries citing papers authored by Hidetaka Masuda
This map shows the geographic impact of Hidetaka Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Masuda more than expected).
Fields of papers citing papers by Hidetaka Masuda
This network shows the impact of papers produced by Hidetaka Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Masuda. The network helps show where Hidetaka Masuda may publish in the future.
Co-authorship network of co-authors of Hidetaka Masuda
This figure shows the co-authorship network connecting the top 25 collaborators of Hidetaka Masuda. A scholar is included among the top collaborators of Hidetaka Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetaka Masuda. Hidetaka Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 16 | |
| 5 | 11 | |
| 6 | 11 | |
| 7 | Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line. | 11 |
| 8 | 11 | |
| 9 | Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system. | 11 |
| 10 | Relationship between Strontium Concentrations in Human Permanent Enamel and Dentin and Dental Diseases | 3 |
| 11 | 20 | |
| 12 | 228 | |
| 13 | 9 | |
| 14 | 25 | |
| 15 | [Therapeutic strategy for adenomatous goiter from the viewpoint of postoperative outcome and epidermal growth factor receptor study]. | 4 |
| 16 | 1 | |
| 17 | [Comparison between the succinate dehydrogenase inhibition test and ATP assay for in vitro chemosensitivity testing]. | 4 |
| 18 | In vitro chemosensitivity of various human tumors evaluated by succinate dehydrogenase inhibition (SDI) test (the second report) | 2 |
| 19 | 3 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.